Bausch Health Companies Inc.
BHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,625,000 | $8,757,000 | $8,124,000 | $8,434,000 |
| % Growth | 9.9% | 7.8% | -3.7% | – |
| Cost of Goods Sold | $2,782,000 | $2,559,000 | $2,364,000 | $2,394,000 |
| Gross Profit | $6,843,000 | $6,198,000 | $5,760,000 | $6,040,000 |
| % Margin | 71.1% | 70.8% | 70.9% | 71.6% |
| R&D Expenses | $634,000 | $604,000 | $530,000 | $473,000 |
| G&A Expenses | $2,497,000 | $2,270,000 | $2,013,000 | $1,977,000 |
| SG&A Expenses | $3,283,000 | $2,895,000 | $2,531,000 | $2,492,000 |
| Sales & Mktg Exp. | $786,000 | $625,000 | $518,000 | $515,000 |
| Other Operating Expenses | $1,380,000 | $1,736,000 | $2,245,000 | $2,625,000 |
| Operating Expenses | $5,297,000 | $5,235,000 | $5,306,000 | $5,590,000 |
| Operating Income | $1,546,000 | $963,000 | $454,000 | $450,000 |
| % Margin | 16.1% | 11% | 5.6% | 5.3% |
| Other Income/Exp. Net | -$1,379,000 | -$1,353,000 | -$583,000 | -$1,474,000 |
| Pre-Tax Income | $167,000 | -$390,000 | -$129,000 | -$1,024,000 |
| Tax Expense | $239,000 | $221,000 | $83,000 | -$87,000 |
| Net Income | -$46,000 | -$592,000 | -$225,000 | -$948,000 |
| % Margin | -0.5% | -6.8% | -2.8% | -11.2% |
| EPS | -0.13 | -1.62 | -0.59 | -2.61 |
| % Growth | 92% | -174.6% | 77.4% | – |
| EPS Diluted | -0.13 | -1.62 | -0.59 | -2.61 |
| Weighted Avg Shares Out | 368,000 | 365,432 | 362,000 | 358,900 |
| Weighted Avg Shares Out Dil | 368,000 | 364,900 | 362,000 | 358,900 |
| Supplemental Information | – | – | – | – |
| Interest Income | $33,000 | $26,000 | $14,000 | $7,000 |
| Interest Expense | $1,388,000 | $1,328,000 | $1,464,000 | $1,426,000 |
| Depreciation & Amortization | $1,267,000 | $1,264,000 | $1,394,000 | $1,552,000 |
| EBITDA | $3,134,000 | $2,885,000 | $2,878,000 | $3,260,000 |
| % Margin | 32.6% | 32.9% | 35.4% | 38.7% |